Author Archives: helen

AMMF was delighted to report a few months ago that it had been agreed with Imperial College that the charity would fund a Research Fellowship for a year. Dr Abigail Zabron has now begun her research work and has written … Continue reading →

The following is a brief summary of Tyson and El-Serag’s paper reviewing scientific literature up to and including March 2011, entitled “Risk Factors for Cholangiocarcinoma”, which was recently published in the journal Hepatology. (The following technical translation of the published … Continue reading →

AMMF’s meeting with CRUK to discuss the charity’s financial support of the BILCAP trial, and to seek answers to various queries. Continue reading →

AMMF’s Imperial College Meeting Summary On Thursday 28 July, a gloriously sunny day in London, AMMF representatives, Helen Morement, Noel Corrigan and Dr Ruth Corrigan, met with the Imperial College cholangiocarcinoma research team to find out what is currently happening … Continue reading →

Malcolm Robinson has climbed Pen-y-Ghent in the Yorkshire Dales several times in the past but, following a diagnosis of cholangiocarcinoma in 2010, major surgery and chemotherapy, it was something he doubted he would do again. So undertaking this climb again … Continue reading →

The Government’s new cancer strategy, “Improving Outcomes: a Strategy for Cancer”, has set an objective of saving an additional 5,000 lives by 2014/15.  Taking into account the incidence and mortality associated with rarer cancers, it would be reasonable to assume … Continue reading →

To download a pdf copy of the latest AMMF newsletter, click here

The Mayo Clinic in the USA is performing liver transplantation for cholangiocarcinoma – an aggressive protocol that they say is exhibiting dramatic increases in survival rates and offers new hope for patients with cholangiocarcinoma. They also say they are the … Continue reading →